Peptic Ulcer Disease: Treatments, Supplement Evidence and Safety

Peptic-ulcer treatment needs both healing care and attention to the cause. H. pylori and NSAIDs are the main causes. Confidence is high in the need to assess bleeding or severe pain promptly. This guide does not establish an independently funded supplement cure or a personal antibiotic regimen.

Table of contents

• Evidence summary
• What is peptic ulcer disease?
• How it works
• The evidence-based treatments
• Supplement and lifestyle evidence
• What works and what does not
• Risks and side effects
• Important interactions
• Who needs special assessment
• Clinician-led treatment and use
• Animal and in-vitro evidence
• Funding and source roles
• Frequently asked questions
• Sources and funding notes

Evidence summary

Clinical guidance, human outcome research and funding independence answer different questions. The guidance below explains care; it does not independently reproduce the trials behind a medicine or supplement.

What is peptic ulcer disease?

A peptic ulcer is an open sore in the lining of the stomach or the duodenum, the first part of the small intestine. A stomach ulcer is also called a gastric ulcer. “Peptic ulcer disease” groups these related locations, so different names do not necessarily describe separate illnesses. NIDDK definition.

The main symptom can be upper abdominal pain, sometimes burning or intermittent. Some people experience fullness, nausea, bloating or belching; others have no obvious symptoms until a complication occurs. A pattern of discomfort cannot establish the location or cause of an ulcer on its own. NIDDK symptoms.

This guide concerns ulcers in the digestive tract. Mouth ulcers, ulcerative colitis and a nonspecific feeling of indigestion have different diagnostic meanings. The shared word “ulcer” does not make their treatments interchangeable. Ask which diagnosis has actually been established before using a product marketed for a different condition.

How it works

H. pylori infection and nonsteroidal anti-inflammatory drugs, including aspirin, ibuprofen and naproxen, are the most common causes. NSAIDs can make the stomach lining more vulnerable to damage. Using them for longer, at higher amounts or in combination with other relevant medicines can increase risk. NIDDK causes and risk factors.

A clinician reviews symptoms, past ulcers, medicine use and family history. Tests can investigate H. pylori, and upper endoscopy can show the stomach and duodenal lining and obtain biopsies. A breath or stool infection test answers a different question from directly identifying an ulcer. NIDDK diagnostic pathway.

Ulcers that persist or recur require reassessment rather than an assumption that ordinary stress or one food explains them. NIDDK also describes less common causes, including some other illnesses, procedures and acid-producing gastrinomas in Zollinger–Ellison syndrome. An unusual cause needs specialist evaluation, not an unstructured supplement experiment. NIDDK uncommon causes.

The evidence-based treatments

Treatment usually aims both to heal the ulcer and to address its cause. Acid-reducing medicines, such as proton pump inhibitors, may be used. H. pylori requires a prescribed combination treatment, while an NSAID-related ulcer calls for a review of the pain medicine and the reason it is needed. NHS cause-directed treatment.

The clinician may consider changing an NSAID or protective treatment when it remains necessary. If infection treatment does not succeed, the next plan can depend on previous antibiotic exposure and possible resistance. These are clinical decisions; this guide supplies no antibiotic recipe, dose or brand ranking. NIDDK treatment of causes.

Follow-up needs to be planned. The 2024 ACG guideline calls for an appropriately timed post-treatment test to confirm H. pylori eradication. Feeling better does not reliably confirm cure. Medicines can alter test accuracy, so preparation should be coordinated with the clinician rather than stopping important treatment independently. Original test-of-cure guidance.

Complications such as significant bleeding or perforation are treated in hospital and may need an endoscopic procedure or surgery. They are not circumstances for waiting to see whether a food change or herbal product works. NIDDK complication care.

Supplement and lifestyle evidence

NIDDK does not recommend a universal special diet to prevent or treat peptic ulcers. A food may worsen a person’s discomfort without being the underlying ulcer cause. Smoking cessation can support risk reduction and healing; it does not replace infection treatment or the medication review. NIDDK nutrition context.

A symptom record can help explain how eating affects daily comfort. It cannot show that the sore has healed. If removing several foods leaves you eating very little, discuss how to maintain adequate intake and whether symptoms require further investigation. Avoid treating nutritional restriction as proof of disease control.

Licorice is often promoted for digestive symptoms, but NCCIH reports that high-quality evidence is insufficient to clearly support its use for a health condition. The glycyrrhizin-containing form has important safety risks. “Deglycyrrhizinated” describes a changed formulation; it does not itself establish ulcer healing or H. pylori clearance. NCCIH licorice evidence and safety.

Probiotics vary by organism and product. The original 2024 ACG guideline found insufficient evidence to suggest routine probiotic improvement of eradication effectiveness or tolerability. We report that as conflicted professional guidance, not a finance-cleared trial conclusion. No independent supplement product ranking is awarded here. Guideline probiotic assessment; NCCIH product specificity.

What works and what does not

The useful distinction is between symptom relief, ulcer healing and infection eradication. They can occur together, but one does not demonstrate all three. An antacid-like effect, less bloating or a positive testimonial does not show that an ulcer has healed or the bacteria are gone.

The test and follow-up plan should answer the actual problem. Ask whether the initial diagnosis identified an ulcer, active infection, another cause of discomfort or several problems together. This prevents repeated treatment aimed at a label that was never established. NIDDK tests and their purpose.

A “stomach lining repair” supplement or an antimicrobial herb does not receive an independent efficacy verdict merely because laboratory experiments suggest a relevant mechanism. A meaningful human study would need confirmed disease, suitable comparison and healing or eradication outcomes, together with a traceable financial record. Those conditions are not established for a supplement treatment in this guide.

Risks and side effects

Ulcer complications include bleeding, a hole in the digestive wall and obstruction of food leaving the stomach. Symptoms do not need to have been dramatic beforehand for a complication to occur. NIDDK notes that some people have no symptoms until complications develop. NIDDK complications.

Get emergency help for blood or coffee-ground material in vomit, bloody or black sticky stool, severe abdominal pain or an abdomen painful to touch. Sudden chest pain also needs emergency assessment. These symptoms should not be labelled ordinary indigestion or watched at home while trying a supplement. NHS emergency signs.

Persistent or worsening pain, repeated vomiting, unintentional weight loss, appetite loss or difficulty swallowing warrant prompt clinical assessment. Bring the medicine list, particularly if aspirin, anticoagulants or anti-inflammatory painkillers are involved. The next assessment may need to examine more than the previous ulcer diagnosis. NHS urgent assessment.

Important interactions

NSAIDs can cause problems when combined with another NSAID, anticoagulants, steroids, some antidepressants or certain blood-pressure medicines. Do not assume that a painkiller sold without a prescription is separate from the medicine list. The pharmacist should see both prescription and nonprescription products. NHS NSAID interactions.

Aspirin may be prescribed to reduce blood-clot risk rather than for pain. The NHS advises people taking regular low-dose aspirin to continue unless advised to stop. An ulcer concern therefore requires a coordinated benefit-and-risk review; do not interpret a general NSAID warning as permission to abandon prescribed cardiovascular protection. NHS aspirin precautions.

Licorice has reported interactions with corticosteroids and can cause serious cardiovascular effects. Product formulation, other medicines and existing heart or kidney illness matter. A herbal blend must be checked ingredient by ingredient, rather than assumed safe because it is marketed for digestion. NCCIH interaction and safety cautions.

Who needs special assessment

Older adults, people with a previous ulcer and those taking relevant medicines need an individual risk review. H. pylori and NSAID use can coexist. A diagnosis of infection does not remove the need to examine a painkiller’s contribution, and an NSAID history does not automatically exclude infection. NIDDK risk context; NIDDK overlapping risks.

Pregnancy, breastfeeding, kidney or liver disease and treatment with several medicines require extra care in medicine selection. NSAID and aspirin suitability can differ by purpose and circumstances. This educational guide cannot make that decision; use a clinician or pharmacist who can review the actual treatment. NHS suitability; NHS aspirin assessment.

NCCIH highlights particular licorice concerns in people with hypertension or heart and kidney conditions, and warns about oral licorice exposure during pregnancy. General probiotic safety also changes with severe illness or weakened immunity. Supplement availability does not establish suitability for these groups. Licorice vulnerable groups; Probiotic safety limits.

Clinician-led treatment and use

Prepare a timeline of discomfort, vomiting, weight change and bleeding symptoms, together with all pain medicines and previous antibiotics. Bring previous endoscopy or infection-test results if available. State whether aspirin is prescribed for clot prevention or taken for pain, because the reason influences the review.

Ask what is being treated, which outcome will confirm success and when follow-up will occur. If symptoms recur, ask whether the ulcer or infection needs reassessment rather than simply restarting the same medicine. NIDDK describes checking persistent causes and, in some cases, repeat endoscopy or biopsies when ulcers do not heal. NIDDK persistent-ulcer assessment.

Use the prescribed plan and ask promptly about side effects or difficulty completing it. There is no personal PPI duration, antibiotic course, aspirin change or supplement dose here. Test preparation also needs explicit instructions from the clinical team, especially when temporary medicine changes could affect another illness.

Animal and in-vitro evidence

Laboratory studies can examine bacterial growth, acid-related injury or plant compounds in cells and animals. They do not demonstrate ulcer healing, prevention of major bleeding or H. pylori eradication in people. No animal or in-vitro result supports a human efficacy verdict in this guide. The financial independence of a mechanism experiment also does not establish the efficacy or safety of a commercial formulation.

Funding and source roles

NIH and NHS finance routes support public institutional context. They do not clear the authors, proprietary clinical references or all supporting treatment studies. The original ACG guideline lists methodologist funding and commercial author relationships; it is used as labelled clinical context, not an independent drug or supplement ranking.

Grades below are provisional assessments of source credibility and incentives. They are not comparative treatment grades. Corporate-funded efficacy is excluded from the independent verdict; unknown trial finance remains unknown. For this article, no independently cleared supplement trial establishes ulcer healing or infection eradication.

Frequently asked questions

Are stomach and duodenal ulcers different article topics?

They are different locations within peptic ulcer disease. This guide covers both; a location-specific clinical plan can still differ. NIDDK terminology.

Is a special bland diet a cure?

No curative special diet is established here. Individual symptom triggers and cause-directed ulcer treatment are separate questions. NIDDK diet advice.

Can I stop prescribed aspirin because ulcers are a risk?

Arrange a prompt clinical review. Prescribed clot-prevention aspirin has another purpose and should not be independently abandoned because of a general warning. Active bleeding needs emergency care. NHS aspirin advice; bleeding signs.

Does less pain prove H. pylori has cleared?

No. Appropriate follow-up testing is needed; symptoms and microbiological cure are different outcomes. Original follow-up guidance.

Sources and funding notes

NIH/NHS institutional financial documents and the original 2024 ACG guideline’s methodologist-payment and author-conflict statements were checked. The guideline was read as a reproduced original article; its hosting domain is not treated as authorship or funding. Institutional education does not clear proprietary references or all underlying trials. No corporate efficacy trial, animal experiment or marketing claim supports an independent supplement verdict. Regimen selection, geographic resistance patterns and individual treatment risks remain clinician-led.

1. NIDDK: ulcer definition — Stomach/duodenal ulcers and possible complications.
2. NIDDK: ulcer symptoms and causes — H. pylori, NSAIDs and uncommon causes.
3. NIDDK: ulcer diagnosis — History, endoscopy and infection tests.
4. NIDDK: ulcer treatment — Healing treatment and management of the cause, not a drug ranking.
5. NIDDK: ulcer diet — Distinguish dietary triggers from ulcer treatment.
6. NHS: stomach ulcer — Urgent/emergency signs and clinical follow-up.
7. NHS: NSAIDs — Bleeding risks and medicine combinations.
8. NHS: aspirin — Prescribed antiplatelet treatment requires a coordinated review.
9. NCCIH: licorice — Digestive evidence uncertainty and cardiac/renal/pregnancy cautions.
10. NCCIH: probiotics — Strain/product specificity and vulnerable-patient safety.
11. Original ACG H. pylori guideline (2024) — Post-treatment testing and probiotic-evidence context; no independent brand verdict or personal regimen.

Educational information reviewed 4 October 2026. This guide supports an informed clinical discussion; it does not diagnose an individual or provide a personal treatment regimen.